380550 — Neurophet Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Annual balance sheet for Neurophet, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS
Standards:	IFRS	IFRS	IFRS
Status:	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	8,200	18,682	6,017
Net Total Accounts Receivable
Net Total Receivables	237	454	615
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	9,142	19,545	6,888
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	777	2,694	1,992
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	10,977	23,137	9,860
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	588	40,170	59,776
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	588	59,785	61,057
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Other Equity
Total Equity	10,389	-36,648	-51,197
Total Liabilities & Shareholders' Equity	10,977	23,137	9,860
Total Common Shares Outstanding